Patient Case: KC. Optimizing Treatment of Mild to Moderate Ulcerative Colitis: A Case-Based Perspective.

Slides:



Advertisements
Similar presentations
Monotherapy using 6-MP or azathioprine for Crohn’s disease is dead: out with the old and in with the new Stephen B. Hanauer, MD Professor of Medicine Clinical.
Advertisements

Cure’s GTX Licensing Opportunity
UC. Ulcerative Colitis ( UC ) Ulcerative colitis is an inflammatory bowel disease (IBD) that causes chronic inflammation of the digestive tract It is.
Inflammatory Bowel Disease Treatment. Epidemiology Clinical Laboratory Imaging Pathology Response to treatment IBD.
Therapeutic algorithms for Crohn’s disease: Where are we in 2012?
Medical Management of Ulcerative Colitis Conrad Beckett Bradford Royal Infirmary M62 Course March 2006.
Ulcerative colitis.
“Antibiotics and corticosteroids: Indications and approaches”
Dr. Gholam Reza Khatami Ulcerative colitis is a chronic gastrointestinal disease Given modern treatment, medical management is not curative.
STUDY 303 A Phase III, Randomized, Multi-Center, Open-Label, 12 to 14 Month Extension Study to Evaluate the Safety and Tolerability of Mesalamine Given.
Time to initial resolution of rectal bleeding and high stool frequency in patients who achieved clinical and endoscopic remission after up to 8 weeks.
Am J Gastroenterol 2010; 105:1820–1829 F1 박재현. Background Background A novel mouse line with defects in both transforming growth factor- β type II receptor.
GASTROENTEROLOGY 2008; 134 :688–695 소화기내과 R4 이 재 연.
P0866 Combination of Low dose Thiopurine and Allopurinol in patients with ulcerative colitis Please export the Keynote document as a PDF (File – Save as.
Understanding Treatment Goals for Patients With Onychomycosis
Endocrine Combinations in HR-Positive MBC: The Future Is Now
New ESMO Guidance on Tumor Sidedness in mCRC
The Role of Anticholinergic Therapy in Moderate to Severe Asthma
An Endocrinology Clinic in Dyslipidemia
Know Your ABCs: Antiplatelet Therapy, Benefits/Bleeding, and Cardiac Surgery State of the Art: The Role of Antiplatelet Therapy in the Cardiac Surgical.
Goals of Therapy for Patients With UC
Optimizing Use of Biological Agents in Ulcerative Colitis
Patient Presentation. Patient Presentation PRIMO Study Incidence of Muscle Adverse Effects.
At The Cutting Edge of Developments in the Management of Hyperkalemia
From the 2015 Conferences to the Clinic
REFLECT: First-Line Lenvatinib vs Sorafenib in HCC Study Design
Advances in Dyslipidemia: What Have We Learned From ACC 2017
Complicated Cases in Ulcerative Colitis
Comparing Treatment Alternatives in Ankylosing Spondylitis
A Closer Look at Pemphigus Vulgaris: Clinical Challenges and Emerging Treatments.
Program Goals. What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?
Pathways in Managing Ulcerative Colitis
Decision-making in the eRA of Treating to Target
What Is a Biosimilar?. Biosimilar Application in RA Clinical Practice: Current Knowledge and New Data  
Pharmacist Perspectives on Novel Agents in Multiple Myeloma
Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: First-line Considerations.
Fernando Velayos, Uma Mahadevan 
Ask the Experts.
Program Goals Overview Glatiramer Acetate 3 Times a Week.
Illustrations in Ulcerative Colitis
ADVANCED PARKINSON'S DISEASE:
Case: A 28-Year-Old Man. When a 5-ASA Agent No Longer Maintains Remission in a Patient With Ulcerative Colitis.
Advancing the Treatment of IBD With Biologics
Use of Combination of Saxagliptin/ Dapagliflozin in Patients With Poorly Controlled Diabetes on Metformin.
Treatment of Thromboembolic Disease The Need for Multiple Perspectives
Treating CD30-Expressing Cutaneous T-Cell Lymphoma
Management of Systematic Lupus Erythematosus
The Evolving Treatment Landscape in Atopic Dermatitis
Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.
Maintenance Therapy in Advanced Ovarian Cancer
Duration of Dual Antiplatelet Therapy
Understanding and Addressing the Needs of Patients With AD
CAD and HF Often Coexist
Volume 143, Issue 5, Pages e2 (November 2012)
Volume 148, Issue 5, Pages e3 (May 2015)
Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: Considerations for Previously Treated Disease.
Practical Strategies for Getting Patients With Diabetes to Lipid Goal
Prednisolone and Budesonide for Short- and Long-Term Treatment of Microscopic Colitis: Systematic Review and Meta-analysis  Michael J. Stewart, Cynthia.
Optimizing Front-Line Endocrine Therapy in Metastatic Breast Cancer
AMD Therapy: Where Are We Now and Where Are We Going?
Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Phase III randomized controlled trial to compare biosimilar infliximab (CT-P13) with innovator infliximab in patients with active Crohn’s disease: 1-year.
Targeting IL-23 for Therapeutic Longevity in Psoriasis
A Closer Look.
Presentation data from US VICTORY Consortium
Patient and Clinician Perspectives on Preventive Therapy for Migraine
Comparative Studies of Biologics in Ulcerative Colitis
Cox regression analysis of the proportion of patients remaining in remission during azathioprine treatment related to diagnosis of inflammatory bowel disease.
Treatment Advances for RA
Cox regression analysis of the proportion of patients remaining in remission after stopping azathioprine treatment related to diagnosis of inflammatory.
Presentation transcript:

Optimizing Treatment of Mild to Moderate Ulcerative Colitis: A Case-Based Perspective

Patient Case: KC

Flexible Sigmoidoscopy and Laboratory Results

Classification of Disease Severity

Talk to Patients About Their Disease

Sequential Therapies for Ulcerative Colitis

5-ASA Therapies

Recent Advances in 5-ASA Therapy

KC: Patient Case (cont)

Corticosteroids: Short- and Long-term Efficacy for Ulcerative Colitis

Budesonide MMX in Ulcerative Colitis: 8-Week Clinical Remission Rates

Pooled Safety Data: Side Effects of Budesonide MMX in Patients With Active Ulcerative Colitis

KC: Patient Case (cont)

Is KC Steroid Dependent?

Azathioprine vs 5-ASA for Steroid-Dependent, Active Ulcerative Colitis

KC: Patient Case (cont)

Abbreviations

References

References (cont)

References (cont)